Latest News

The Yale Center for Immuno-Oncology was launched in 2018 to build on Yale’s leadership in immunology, cancer biology, and the development of innovative cancer immunotherapies. Bosenberg has served as interim director since 2019.

Researchers from the Yale Department of Immunology and Yale Cancer Center have recently developed a mouse model that displays enhanced human erythropoiesis and mature RBC survival to help them better study human blood disorders.

We Used to Have a Lyme Disease Vaccine. Are We Ready to Bring One Back?

Meet Yale Internal Medicine: Andrew Wang, MD/PhD, AB, Assistant Professor of Medicine (Rheumatology) and Immunobiology

Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus that causes COVID-19, Yale researchers have found.

Three proteins found in the blood of post-COVID patients appear to predict who may have long-term symptoms of the disease.

Yale scientists describe a key molecular “on-off” switch that enables plants to mobilize immunity in the face of microbial pathogens.

Kevan C. Herold, MD, C.N.H. Long Professor of Immunobiology and professor of medicine (endocrinology) at Yale School of Medicine, has been named chair of Type 1 Diabetes (T1D) TrialNet, an international consortium dedicated to finding ways to prevent, delay, and slow progression of the disease.

Yale researchers across a range of disciplines are coming together to explore the important role of microbial metabolites in our microbiota—the trillions of bacterial cells that colonize our intestines.